Coverage dated November 26, 2023 to November 28, 2023
Users of diabetes drug Mounjaro lost more weight than those on Ozempic, large study finds
Headline from East Idaho News, on the newest of 2 developments
(CNN) — Overweight and obese adults who took the injected medication Mounjaro lost more weight and were more likely to meet specific weight loss targets than people on a similar competitor, Ozempic, according to a new study of people taking the drugs in the real world.
East Idaho News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real-world study says
Headline from NBC New York ·
Newest
Users of diabetes drug Mounjaro lost more weight than those on Ozempic, large study finds
Mounjaro, which is the brand name for tirzepatide, was shown to be even more powerful than Ozempic in a recent study with adults who were overweight or obese.
Patients on Eli Lilly’s Mounjaro were more likely to lose weight and experienced larger reductions in body weight compared to those on Novo Nordisk’s Ozempic.
Diabetes-turned-weight loss drug Mounjaro is more effective for shedding off extra pounds than its ultra-popular counterpart, Ozempic, according to a new study.
(CNN) — Overweight and obese adults who took the injected medication Mounjaro lost more weight and were more likely to meet specific weight loss targets than people on a similar competitor, Ozempic, according to a new study of people taking the drugs in the real world.
